nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0529	0.0696	CbGbCtD
Dronabinol—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0371	0.0488	CbGbCtD
Dronabinol—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0348	0.0457	CbGbCtD
Dronabinol—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0336	0.0442	CbGbCtD
Dronabinol—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0336	0.0442	CbGbCtD
Dronabinol—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0322	0.0423	CbGbCtD
Dronabinol—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0249	0.0327	CbGbCtD
Dronabinol—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0233	0.0306	CbGbCtD
Dronabinol—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0219	0.0288	CbGbCtD
Dronabinol—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0198	0.026	CbGbCtD
Dronabinol—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0198	0.026	CbGbCtD
Dronabinol—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0194	0.0255	CbGbCtD
Dronabinol—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0182	0.0239	CbGbCtD
Dronabinol—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0182	0.0239	CbGbCtD
Dronabinol—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0177	0.0232	CbGbCtD
Dronabinol—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0171	0.0225	CbGbCtD
Dronabinol—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0166	0.0218	CbGbCtD
Dronabinol—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0165	0.0216	CbGbCtD
Dronabinol—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0165	0.0216	CbGbCtD
Dronabinol—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.016	0.021	CbGbCtD
Dronabinol—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0197	CbGbCtD
Dronabinol—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0197	CbGbCtD
Dronabinol—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.0189	CbGbCtD
Dronabinol—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0142	0.0187	CbGbCtD
Dronabinol—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0138	0.0181	CbGbCtD
Dronabinol—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0138	0.0181	CbGbCtD
Dronabinol—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0176	CbGbCtD
Dronabinol—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0125	0.0164	CbGbCtD
Dronabinol—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0125	0.0164	CbGbCtD
Dronabinol—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0121	0.0159	CbGbCtD
Dronabinol—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0159	CbGbCtD
Dronabinol—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.012	0.0157	CbGbCtD
Dronabinol—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0116	0.0153	CbGbCtD
Dronabinol—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0113	0.0148	CbGbCtD
Dronabinol—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0106	0.0139	CbGbCtD
Dronabinol—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0106	0.0139	CbGbCtD
Dronabinol—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00957	0.0126	CbGbCtD
Dronabinol—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00957	0.0126	CbGbCtD
Dronabinol—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00898	0.0118	CbGbCtD
Dronabinol—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00826	0.0109	CbGbCtD
Dronabinol—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00802	0.0105	CbGbCtD
Dronabinol—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00725	0.00954	CbGbCtD
Dronabinol—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00725	0.00954	CbGbCtD
Dronabinol—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00696	0.00915	CbGbCtD
Dronabinol—CNR2—lymphoid tissue—acquired immunodeficiency syndrome	0.00333	0.0787	CbGeAlD
Dronabinol—CNR2—blood—acquired immunodeficiency syndrome	0.00313	0.074	CbGeAlD
Dronabinol—CNR2—nervous system—acquired immunodeficiency syndrome	0.00254	0.0601	CbGeAlD
Dronabinol—CNR2—central nervous system—acquired immunodeficiency syndrome	0.00245	0.0579	CbGeAlD
Dronabinol—CNR2—brain—acquired immunodeficiency syndrome	0.00194	0.0459	CbGeAlD
Dronabinol—CNR1—lung—acquired immunodeficiency syndrome	0.00191	0.0452	CbGeAlD
Dronabinol—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00149	0.0352	CbGeAlD
Dronabinol—CNR1—brain—acquired immunodeficiency syndrome	0.00135	0.032	CbGeAlD
Dronabinol—CNR1—lymph node—acquired immunodeficiency syndrome	0.00131	0.0309	CbGeAlD
Dronabinol—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00119	0.028	CbGeAlD
Dronabinol—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0273	CbGeAlD
Dronabinol—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0249	CbGeAlD
Dronabinol—CNR1—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00103	0.0434	CbGpPWpGaD
Dronabinol—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00088	0.0208	CbGeAlD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000809	0.034	CbGpPWpGaD
Dronabinol—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000786	0.0186	CbGeAlD
Dronabinol—CYP2A6—lung—acquired immunodeficiency syndrome	0.000743	0.0176	CbGeAlD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000635	0.0267	CbGpPWpGaD
Dronabinol—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000623	0.0147	CbGeAlD
Dronabinol—CNR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000616	0.0259	CbGpPWpGaD
Dronabinol—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000576	0.0136	CbGeAlD
Dronabinol—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000572	0.0135	CbGeAlD
Dronabinol—CYP2C19—blood—acquired immunodeficiency syndrome	0.000545	0.0129	CbGeAlD
Dronabinol—CYP2A6—brain—acquired immunodeficiency syndrome	0.000526	0.0124	CbGeAlD
Dronabinol—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000506	0.012	CbGeAlD
Dronabinol—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000505	0.0119	CbGeAlD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00049	0.0206	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000483	0.0203	CbGpPWpGaD
Dronabinol—ABCG2—blood—acquired immunodeficiency syndrome	0.000463	0.0109	CbGeAlD
Dronabinol—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000461	0.0109	CbGeAlD
Dronabinol—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000448	0.0106	CbGeAlD
Dronabinol—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000446	0.0105	CbGeAlD
Dronabinol—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000444	0.0105	CbGeAlD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000443	0.0186	CbGpPWpGaD
Dronabinol—CYP1A1—blood—acquired immunodeficiency syndrome	0.000439	0.0104	CbGeAlD
Dronabinol—ABCG2—vagina—acquired immunodeficiency syndrome	0.000429	0.0101	CbGeAlD
Dronabinol—CYP2C9—blood—acquired immunodeficiency syndrome	0.000423	0.00998	CbGeAlD
Dronabinol—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000407	0.00962	CbGeAlD
Dronabinol—ABCG2—lung—acquired immunodeficiency syndrome	0.000406	0.00958	CbGeAlD
Dronabinol—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000405	0.00957	CbGeAlD
Dronabinol—PTGS1—blood—acquired immunodeficiency syndrome	0.000386	0.00911	CbGeAlD
Dronabinol—CYP1A1—lung—acquired immunodeficiency syndrome	0.000385	0.00909	CbGeAlD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000385	0.0161	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000373	0.0157	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000372	0.0156	CbGpPWpGaD
Dronabinol—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000372	0.00878	CbGeAlD
Dronabinol—PTGS1—vagina—acquired immunodeficiency syndrome	0.000358	0.00845	CbGeAlD
Dronabinol—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000357	0.00842	CbGeAlD
Dronabinol—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000349	0.00202	CcSEcCtD
Dronabinol—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00201	CcSEcCtD
Dronabinol—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00201	CcSEcCtD
Dronabinol—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00201	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000348	0.0146	CbGpPWpGaD
Dronabinol—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000347	0.002	CcSEcCtD
Dronabinol—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000347	0.002	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00199	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000344	0.0145	CbGpPWpGaD
Dronabinol—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000344	0.00198	CcSEcCtD
Dronabinol—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000343	0.00811	CbGeAlD
Dronabinol—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000343	0.00198	CcSEcCtD
Dronabinol—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.00197	CcSEcCtD
Dronabinol—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00197	CcSEcCtD
Dronabinol—ABCB1—retina—acquired immunodeficiency syndrome	0.000341	0.00806	CbGeAlD
Dronabinol—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00197	CcSEcCtD
Dronabinol—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00197	CcSEcCtD
Dronabinol—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000341	0.00197	CcSEcCtD
Dronabinol—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00034	0.00196	CcSEcCtD
Dronabinol—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.00195	CcSEcCtD
Dronabinol—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000338	0.00799	CbGeAlD
Dronabinol—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000338	0.00195	CcSEcCtD
Dronabinol—PTGS1—lung—acquired immunodeficiency syndrome	0.000338	0.00799	CbGeAlD
Dronabinol—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000338	0.00195	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000337	0.0142	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00195	CcSEcCtD
Dronabinol—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00194	CcSEcCtD
Dronabinol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000336	0.00194	CcSEcCtD
Dronabinol—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00193	CcSEcCtD
Dronabinol—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00193	CcSEcCtD
Dronabinol—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00193	CcSEcCtD
Dronabinol—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00192	CcSEcCtD
Dronabinol—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000332	0.00192	CcSEcCtD
Dronabinol—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.00191	CcSEcCtD
Dronabinol—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.0019	CcSEcCtD
Dronabinol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000329	0.0019	CcSEcCtD
Dronabinol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000328	0.00189	CcSEcCtD
Dronabinol—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00189	CcSEcCtD
Dronabinol—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000327	0.00189	CcSEcCtD
Dronabinol—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000327	0.00189	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000327	0.00188	CcSEcCtD
Dronabinol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000326	0.00188	CcSEcCtD
Dronabinol—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00188	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00188	CcSEcCtD
Dronabinol—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000326	0.00188	CcSEcCtD
Dronabinol—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.00188	CcSEcCtD
Dronabinol—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000325	0.00188	CcSEcCtD
Dronabinol—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00187	CcSEcCtD
Dronabinol—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000324	0.00187	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000324	0.0136	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000324	0.0136	CbGpPWpGaD
Dronabinol—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.00186	CcSEcCtD
Dronabinol—CYP3A4—blood—acquired immunodeficiency syndrome	0.000322	0.00761	CbGeAlD
Dronabinol—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00186	CcSEcCtD
Dronabinol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00186	CcSEcCtD
Dronabinol—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000321	0.00185	CcSEcCtD
Dronabinol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000321	0.00185	CcSEcCtD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00032	0.0134	CbGpPWpGaD
Dronabinol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000319	0.00184	CcSEcCtD
Dronabinol—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000318	0.00183	CcSEcCtD
Dronabinol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00183	CcSEcCtD
Dronabinol—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00183	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000316	0.0133	CbGpPWpGaD
Dronabinol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00182	CcSEcCtD
Dronabinol—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00181	CcSEcCtD
Dronabinol—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00181	CcSEcCtD
Dronabinol—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000313	0.0074	CbGeAlD
Dronabinol—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.0018	CcSEcCtD
Dronabinol—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.00179	CcSEcCtD
Dronabinol—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00178	CcSEcCtD
Dronabinol—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000309	0.00178	CcSEcCtD
Dronabinol—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00178	CcSEcCtD
Dronabinol—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00178	CcSEcCtD
Dronabinol—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.00177	CcSEcCtD
Dronabinol—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.00177	CcSEcCtD
Dronabinol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000306	0.00177	CcSEcCtD
Dronabinol—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00177	CcSEcCtD
Dronabinol—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.00176	CcSEcCtD
Dronabinol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000305	0.00176	CcSEcCtD
Dronabinol—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00176	CcSEcCtD
Dronabinol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.00176	CcSEcCtD
Dronabinol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00175	CcSEcCtD
Dronabinol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00175	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000304	0.00175	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000303	0.0127	CbGpPWpGaD
Dronabinol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000302	0.00174	CcSEcCtD
Dronabinol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00174	CcSEcCtD
Dronabinol—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000302	0.00712	CbGeAlD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0003	0.0126	CbGpPWpGaD
Dronabinol—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00173	CcSEcCtD
Dronabinol—Rash—Didanosine—acquired immunodeficiency syndrome	0.0003	0.00173	CcSEcCtD
Dronabinol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000299	0.00173	CcSEcCtD
Dronabinol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000299	0.00173	CcSEcCtD
Dronabinol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00172	CcSEcCtD
Dronabinol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000298	0.00172	CcSEcCtD
Dronabinol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000297	0.00171	CcSEcCtD
Dronabinol—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00171	CcSEcCtD
Dronabinol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00171	CcSEcCtD
Dronabinol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000296	0.00171	CcSEcCtD
Dronabinol—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00171	CcSEcCtD
Dronabinol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.0017	CcSEcCtD
Dronabinol—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.0017	CcSEcCtD
Dronabinol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.00169	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000293	0.0123	CbGpPWpGaD
Dronabinol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00169	CcSEcCtD
Dronabinol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000293	0.00169	CcSEcCtD
Dronabinol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000292	0.00169	CcSEcCtD
Dronabinol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000292	0.00168	CcSEcCtD
Dronabinol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000291	0.00168	CcSEcCtD
Dronabinol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.00168	CcSEcCtD
Dronabinol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.00168	CcSEcCtD
Dronabinol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00168	CcSEcCtD
Dronabinol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00167	CcSEcCtD
Dronabinol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00167	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.00167	CcSEcCtD
Dronabinol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00166	CcSEcCtD
Dronabinol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00166	CcSEcCtD
Dronabinol—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00166	CcSEcCtD
Dronabinol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00166	CcSEcCtD
Dronabinol—ABCG2—brain—acquired immunodeficiency syndrome	0.000287	0.00678	CbGeAlD
Dronabinol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.00166	CcSEcCtD
Dronabinol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00165	CcSEcCtD
Dronabinol—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.00164	CcSEcCtD
Dronabinol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00164	CcSEcCtD
Dronabinol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00163	CcSEcCtD
Dronabinol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000283	0.00163	CcSEcCtD
Dronabinol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00163	CcSEcCtD
Dronabinol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000282	0.00163	CcSEcCtD
Dronabinol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00162	CcSEcCtD
Dronabinol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00162	CcSEcCtD
Dronabinol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00162	CcSEcCtD
Dronabinol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00161	CcSEcCtD
Dronabinol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00161	CcSEcCtD
Dronabinol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000278	0.0016	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.0016	CcSEcCtD
Dronabinol—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000277	0.00655	CbGeAlD
Dronabinol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.0016	CcSEcCtD
Dronabinol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00159	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00158	CcSEcCtD
Dronabinol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00158	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000274	0.0115	CbGpPWpGaD
Dronabinol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00158	CcSEcCtD
Dronabinol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00158	CcSEcCtD
Dronabinol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.00158	CcSEcCtD
Dronabinol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.00158	CcSEcCtD
Dronabinol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000273	0.00157	CcSEcCtD
Dronabinol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00157	CcSEcCtD
Dronabinol—CYP1A1—brain—acquired immunodeficiency syndrome	0.000273	0.00644	CbGeAlD
Dronabinol—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00157	CcSEcCtD
Dronabinol—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00157	CcSEcCtD
Dronabinol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00157	CcSEcCtD
Dronabinol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00156	CcSEcCtD
Dronabinol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00156	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00027	0.0113	CbGpPWpGaD
Dronabinol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00155	CcSEcCtD
Dronabinol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000269	0.00155	CcSEcCtD
Dronabinol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000269	0.00155	CcSEcCtD
Dronabinol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000269	0.00155	CcSEcCtD
Dronabinol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00155	CcSEcCtD
Dronabinol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000268	0.00154	CcSEcCtD
Dronabinol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00154	CcSEcCtD
Dronabinol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00153	CcSEcCtD
Dronabinol—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00153	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00153	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000265	0.0111	CbGpPWpGaD
Dronabinol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00152	CcSEcCtD
Dronabinol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000264	0.00152	CcSEcCtD
Dronabinol—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000263	0.00622	CbGeAlD
Dronabinol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00152	CcSEcCtD
Dronabinol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00151	CcSEcCtD
Dronabinol—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000262	0.00618	CbGeAlD
Dronabinol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00151	CcSEcCtD
Dronabinol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000261	0.0015	CcSEcCtD
Dronabinol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000261	0.0015	CcSEcCtD
Dronabinol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.0015	CcSEcCtD
Dronabinol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.0015	CcSEcCtD
Dronabinol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00026	0.0015	CcSEcCtD
Dronabinol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.0015	CcSEcCtD
Dronabinol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00026	0.0015	CcSEcCtD
Dronabinol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.0015	CcSEcCtD
Dronabinol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.0015	CcSEcCtD
Dronabinol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.0015	CcSEcCtD
Dronabinol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00149	CcSEcCtD
Dronabinol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00149	CcSEcCtD
Dronabinol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00149	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000257	0.0108	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000257	0.0108	CbGpPWpGaD
Dronabinol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000257	0.00148	CcSEcCtD
Dronabinol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000256	0.00148	CcSEcCtD
Dronabinol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000256	0.00148	CcSEcCtD
Dronabinol—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00148	CcSEcCtD
Dronabinol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000255	0.00147	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000254	0.0107	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000254	0.0107	CbGpPWpGaD
Dronabinol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00146	CcSEcCtD
Dronabinol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000254	0.00146	CcSEcCtD
Dronabinol—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000252	0.00595	CbGeAlD
Dronabinol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00145	CcSEcCtD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000251	0.0105	CbGpPWpGaD
Dronabinol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00145	CcSEcCtD
Dronabinol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00144	CcSEcCtD
Dronabinol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00143	CcSEcCtD
Dronabinol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.00143	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000248	0.0104	CbGpPWpGaD
Dronabinol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00143	CcSEcCtD
Dronabinol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00143	CcSEcCtD
Dronabinol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.00142	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000246	0.0103	CbGpPWpGaD
Dronabinol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00142	CcSEcCtD
Dronabinol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000245	0.00142	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00141	CcSEcCtD
Dronabinol—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00141	CcSEcCtD
Dronabinol—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000242	0.00573	CbGeAlD
Dronabinol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.0014	CcSEcCtD
Dronabinol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00139	CcSEcCtD
Dronabinol—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000239	0.00566	CbGeAlD
Dronabinol—PTGS1—brain—acquired immunodeficiency syndrome	0.000239	0.00566	CbGeAlD
Dronabinol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000239	0.00138	CcSEcCtD
Dronabinol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00138	CcSEcCtD
Dronabinol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00138	CcSEcCtD
Dronabinol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00137	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000238	0.00998	CbGpPWpGaD
Dronabinol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.00137	CcSEcCtD
Dronabinol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000236	0.00136	CcSEcCtD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000236	0.0099	CbGpPWpGaD
Dronabinol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00135	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00135	CcSEcCtD
Dronabinol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00134	CcSEcCtD
Dronabinol—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000231	0.00546	CbGeAlD
Dronabinol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00133	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000231	0.00968	CbGpPWpGaD
Dronabinol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00133	CcSEcCtD
Dronabinol—ABCB1—blood—acquired immunodeficiency syndrome	0.000228	0.00539	CbGeAlD
Dronabinol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000228	0.00132	CcSEcCtD
Dronabinol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00131	CcSEcCtD
Dronabinol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00131	CcSEcCtD
Dronabinol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.0013	CcSEcCtD
Dronabinol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.0013	CcSEcCtD
Dronabinol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.0013	CcSEcCtD
Dronabinol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.0013	CcSEcCtD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000224	0.00943	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000224	0.00943	CbGpPWpGaD
Dronabinol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.00129	CcSEcCtD
Dronabinol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00128	CcSEcCtD
Dronabinol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00128	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000222	0.00932	CbGpPWpGaD
Dronabinol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00128	CcSEcCtD
Dronabinol—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000221	0.00521	CbGeAlD
Dronabinol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00127	CcSEcCtD
Dronabinol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00127	CcSEcCtD
Dronabinol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00127	CcSEcCtD
Dronabinol—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.00022	0.00519	CbGeAlD
Dronabinol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00127	CcSEcCtD
Dronabinol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000216	0.00125	CcSEcCtD
Dronabinol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.00124	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000215	0.00902	CbGpPWpGaD
Dronabinol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00123	CcSEcCtD
Dronabinol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00122	CcSEcCtD
Dronabinol—ABCB1—vagina—acquired immunodeficiency syndrome	0.000211	0.005	CbGeAlD
Dronabinol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00122	CcSEcCtD
Dronabinol—Rash—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00121	CcSEcCtD
Dronabinol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00121	CcSEcCtD
Dronabinol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00121	CcSEcCtD
Dronabinol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000209	0.0012	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000208	0.00876	CbGpPWpGaD
Dronabinol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.0012	CcSEcCtD
Dronabinol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.00119	CcSEcCtD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000206	0.00865	CbGpPWpGaD
Dronabinol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00118	CcSEcCtD
Dronabinol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00117	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000202	0.00848	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000202	0.00848	CbGpPWpGaD
Dronabinol—ABCB1—lung—acquired immunodeficiency syndrome	0.0002	0.00472	CbGeAlD
Dronabinol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00115	CcSEcCtD
Dronabinol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.00115	CcSEcCtD
Dronabinol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00115	CcSEcCtD
Dronabinol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.00114	CcSEcCtD
Dronabinol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00114	CcSEcCtD
Dronabinol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00114	CcSEcCtD
Dronabinol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00114	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000196	0.00823	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000196	0.00823	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000196	0.00822	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000193	0.00812	CbGpPWpGaD
Dronabinol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.00111	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000191	0.00804	CbGpPWpGaD
Dronabinol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.0011	CcSEcCtD
Dronabinol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.0011	CcSEcCtD
Dronabinol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.0011	CcSEcCtD
Dronabinol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.00109	CcSEcCtD
Dronabinol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.00109	CcSEcCtD
Dronabinol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00109	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000187	0.00784	CbGpPWpGaD
Dronabinol—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000185	0.00437	CbGeAlD
Dronabinol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00106	CcSEcCtD
Dronabinol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00106	CcSEcCtD
Dronabinol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00106	CcSEcCtD
Dronabinol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.00104	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000181	0.0076	CbGpPWpGaD
Dronabinol—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000178	0.00421	CbGeAlD
Dronabinol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.00102	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000176	0.00741	CbGpPWpGaD
Dronabinol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00101	CcSEcCtD
Dronabinol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00101	CcSEcCtD
Dronabinol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.00101	CcSEcCtD
Dronabinol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00101	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000174	0.00731	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000173	0.00727	CbGpPWpGaD
Dronabinol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000976	CcSEcCtD
Dronabinol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000976	CcSEcCtD
Dronabinol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000975	CcSEcCtD
Dronabinol—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000168	0.00707	CbGpPWpGaD
Dronabinol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00097	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000164	0.00687	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000162	0.00679	CbGpPWpGaD
Dronabinol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000931	CcSEcCtD
Dronabinol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.00093	CcSEcCtD
Dronabinol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000925	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000154	0.00646	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000154	0.00646	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000154	0.00645	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00015	0.00631	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000149	0.00626	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000147	0.00615	CbGpPWpGaD
Dronabinol—ABCB1—brain—acquired immunodeficiency syndrome	0.000142	0.00334	CbGeAlD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000138	0.00581	CbGpPWpGaD
Dronabinol—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000137	0.00323	CbGeAlD
Dronabinol—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000136	0.00571	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000136	0.00571	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000134	0.00564	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000121	0.0051	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000121	0.0051	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000118	0.00497	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000118	0.00495	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000117	0.00491	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000113	0.00475	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000113	0.00475	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000111	0.00465	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000111	0.00465	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000107	0.00449	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000105	0.00443	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000105	0.00441	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000102	0.0043	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000101	0.00422	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000101	0.00422	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.28e-05	0.0039	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.25e-05	0.00388	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.17e-05	0.00385	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	9.04e-05	0.0038	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.88e-05	0.00373	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.88e-05	0.00373	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.69e-05	0.00365	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.69e-05	0.00365	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.43e-05	0.00354	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.4e-05	0.00353	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	8.37e-05	0.00351	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.3e-05	0.00349	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	8.03e-05	0.00337	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.03e-05	0.00337	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	7.97e-05	0.00335	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	7.97e-05	0.00335	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.89e-05	0.00332	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.89e-05	0.00332	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	7.75e-05	0.00325	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.65e-05	0.00321	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	7.64e-05	0.00321	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.59e-05	0.00319	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	7.58e-05	0.00318	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.54e-05	0.00317	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.99e-05	0.00294	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.89e-05	0.0029	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.61e-05	0.00278	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.51e-05	0.00274	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.46e-05	0.00271	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.32e-05	0.00265	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.01e-05	0.00252	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.96e-05	0.0025	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.94e-05	0.0025	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.94e-05	0.0025	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.92e-05	0.00248	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.85e-05	0.00246	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.85e-05	0.00246	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.48e-05	0.0023	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.41e-05	0.00227	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.28e-05	0.00222	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	5e-05	0.0021	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.96e-05	0.00208	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	4.94e-05	0.00208	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.82e-05	0.00202	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	4.8e-05	0.00202	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.68e-05	0.00197	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.66e-05	0.00196	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.66e-05	0.00196	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—TAT—acquired immunodeficiency syndrome	4.54e-05	0.00191	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.52e-05	0.0019	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.45e-05	0.00187	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.39e-05	0.00184	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.25e-05	0.00178	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	4.16e-05	0.00175	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.08e-05	0.00171	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.07e-05	0.00171	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	3.99e-05	0.00167	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.98e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.86e-05	0.00162	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.55e-05	0.00149	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.49e-05	0.00147	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.44e-05	0.00145	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	3.38e-05	0.00142	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.2e-05	0.00134	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.13e-05	0.00131	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	3.03e-05	0.00127	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.88e-05	0.00121	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TAT—acquired immunodeficiency syndrome	2.77e-05	0.00116	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.7e-05	0.00113	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	2.52e-05	0.00106	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—AGPS—acquired immunodeficiency syndrome	2.35e-05	0.000988	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.35e-05	0.000988	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.34e-05	0.000983	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.3e-05	0.000965	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.15e-05	0.000901	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.88e-05	0.000789	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.86e-05	0.000781	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.85e-05	0.000776	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.84e-05	0.000772	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.66e-05	0.000699	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.5e-05	0.000628	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.42e-05	0.000594	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000581	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.32e-05	0.000556	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.09e-05	0.000456	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.08e-05	0.000455	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.01e-05	0.000422	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.88e-06	0.000415	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	8.71e-06	0.000366	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	8.37e-06	0.000352	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	7.92e-06	0.000332	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.9e-06	0.000248	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.83e-06	0.000203	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.71e-06	0.000198	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.4e-06	0.000185	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.9e-06	0.000122	CbGpPWpGaD
